A

Apollomics
D

APLMW

0.016000
USD
-0.00
(-13.51%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
1,431,693
المقالات
المزيد

العنوان: Apollomics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.